1. Home
  2. CTS vs SYRE Comparison

CTS vs SYRE Comparison

Compare CTS & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTS
  • SYRE
  • Stock Information
  • Founded
  • CTS 1896
  • SYRE 2013
  • Country
  • CTS United States
  • SYRE United States
  • Employees
  • CTS N/A
  • SYRE N/A
  • Industry
  • CTS Electrical Products
  • SYRE Biotechnology: Pharmaceutical Preparations
  • Sector
  • CTS Technology
  • SYRE Health Care
  • Exchange
  • CTS Nasdaq
  • SYRE Nasdaq
  • Market Cap
  • CTS 1.3B
  • SYRE 1.1B
  • IPO Year
  • CTS N/A
  • SYRE 2016
  • Fundamental
  • Price
  • CTS $41.44
  • SYRE $15.05
  • Analyst Decision
  • CTS
  • SYRE Strong Buy
  • Analyst Count
  • CTS 0
  • SYRE 5
  • Target Price
  • CTS N/A
  • SYRE $61.25
  • AVG Volume (30 Days)
  • CTS 131.3K
  • SYRE 492.5K
  • Earning Date
  • CTS 10-28-2025
  • SYRE 11-06-2025
  • Dividend Yield
  • CTS 0.38%
  • SYRE N/A
  • EPS Growth
  • CTS 18.55
  • SYRE N/A
  • EPS
  • CTS 2.11
  • SYRE N/A
  • Revenue
  • CTS $520,937,000.00
  • SYRE N/A
  • Revenue This Year
  • CTS $4.41
  • SYRE N/A
  • Revenue Next Year
  • CTS $7.00
  • SYRE N/A
  • P/E Ratio
  • CTS $19.74
  • SYRE N/A
  • Revenue Growth
  • CTS 1.12
  • SYRE N/A
  • 52 Week Low
  • CTS $34.02
  • SYRE $10.91
  • 52 Week High
  • CTS $59.68
  • SYRE $40.26
  • Technical
  • Relative Strength Index (RSI)
  • CTS 47.49
  • SYRE 37.57
  • Support Level
  • CTS $41.07
  • SYRE $14.67
  • Resistance Level
  • CTS $42.91
  • SYRE $17.58
  • Average True Range (ATR)
  • CTS 0.82
  • SYRE 0.74
  • MACD
  • CTS -0.12
  • SYRE -0.23
  • Stochastic Oscillator
  • CTS 17.13
  • SYRE 13.21

About CTS CTS Corporation

CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEM) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China; Singapore; the Czech Republic; Taiwan, Denmark, and other countries.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: